Abstract
Introduction: In patients with heart failure (HF) caused by MI, the BioVentrix Revivent TC system offers a less invasive alternative to surgical ventricular restoration by avoiding cardiopulmonary bypass, cardioplegic arrest, or ventriculotomy. 12-month results on 86 patients (European Journal of Heart Failure) have observed improvement in left ventricular volumes, ejection fraction, and better quality of life (Qol).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have